BPC-157 and bone: what the rabbit and rodent studies examined

Prepared by: Research Desk. Sources are linked for verification.

Status: Not approved. BPC-157 is not FDA-approved for any use. It appears on FDA's page of bulk drug substances for compounding that may present significant safety risks [2], and it is prohibited in sport under the WADA anti-doping rules [4]. See our legal status file for the dated record.

Searches for "BPC-157 bone" often turn up confident claims about fractures and bone repair. The published record behind those claims is narrow. The bone-related work is animal research, including rabbit and rodent experiments, and most of it comes from a single research group in Zagreb, Croatia. No human bone study appears among the sources cited on this page. This explainer covers how bone experiments of this kind are designed, what they measure, what we could and could not confirm, and where the gaps are.

This page is deliberately narrow. For the wider picture of rodent research across tissues, see our overview of BPC-157 animal studies. For the closest neighbouring tissue, see BPC-157 tendon research.

Where bone fits in the BPC-157 literature

BPC-157 is a synthetic pentadecapeptide, a chain of 15 amino acids, which its originating research group calls a "stable gastric pentadecapeptide" [9][11]. Most of the early research came from that one Zagreb group, which originally focused on the stomach and gut. Over time the same group extended its experiments to other tissues. Their reviews describe work on wound repair across several tissue types [9] and on striated, smooth and heart muscle [11].

Bone sits at the edge of this literature. A 2025 systematic review examined the emerging use of BPC-157 in orthopaedic sports medicine, the field the bone experiments belong to [1]. A 2026 review in the American Journal of Sports Medicine also discusses BPC-157 among peptide products used in sports medicine [10]. Neither review changes the basic picture: the bone evidence is preclinical.

What we could and could not confirm

Secondary summaries of the BPC-157 literature refer to a rabbit bone-defect experiment from the late 1990s and to fracture models in rats and other rodents. The primary papers behind those references are not among the verified sources this page cites. For that reason we do not report their specific designs, group sizes, comparison groups or results here. Repeating those details second-hand would mean presenting claims we cannot link for verification.

What we can do is explain how bone experiments of this type are generally built, so that readers who go to the original papers know what to look for.

How animal bone experiments are designed

Common models

• Segmental defect models. A short section of bone, often with its outer membrane (the periosteum), is surgically removed, usually from a long bone in a limb. Researchers then track whether and how the gap fills over a set period. Rabbits are a common species for this kind of model because their limb bones are large enough for standardised surgery.

• Fracture models. A bone, often the femur or tibia in rats, is deliberately broken under controlled conditions and sometimes stabilised with a pin. The fracture is then followed over time.

• Comparison groups. A well-designed experiment compares the test substance with an inactive control, and sometimes with an established surgical comparator such as a bone graft, so that results can be judged against a known reference.

Common outcome measures

• Radiography: X-ray images scored for callus formation (the bridging tissue that forms across a break) and for closure of the gap.

• Densitometry: measurements of how dense the bone region appears on imaging.

• Histomorphometry: thin tissue slices examined under a microscope and measured for features such as new bone, cartilage and callus.

• Mechanical testing: in some studies, the bone is removed at the end and tested for stiffness or breaking strength.

Each measure answers a different question. Imaging shows whether the gap looks bridged; microscopy shows what kind of tissue is present; mechanical testing shows whether the bone can bear load. A study that reports only imaging scores says less than one that reports all three.

How to read any bone experiment

1. One species, one injury type. A surgically created defect in a rabbit or rat limb is a standardised injury. It is not a model of the fractures, stress injuries or bone conditions people search about.

2. Follow-up length. Experiments lasting a few weeks capture early callus and bridging. They say little about long-term remodelling, strength or durability.

3. Same-group origin. When most experiments come from the group that originated a compound, independent replication matters. Clear replication of bone findings by unrelated laboratories is not documented in the sources we cite.

4. Group size and scoring. Animal experiments often use small groups, which makes results more sensitive to chance. Whether the people scoring X-rays and tissue slides knew which group each animal was in is worth checking in any original paper.

5. Skeletal differences. Rodent and rabbit skeletons differ from human ones in size, loading and remodelling rate, which is one reason animal results do not automatically carry over to people.

Our checklist for evaluating BPC-157 studies covers each of these points in more depth.

The proposed mechanism and the angiogenesis question

Bone repair depends on the growth of new blood vessels (angiogenesis), and much of the BPC-157 literature proposes effects on angiogenesis and nitric oxide signalling. A 2025 published exchange in Pharmaceuticals shows that how these vascular effects should be framed is itself debated. Sikiric and colleagues commented on a literature and patent review by Józwiak and colleagues, and the review authors published a reply; the titles of the exchange centre on angiogenesis and nitric oxide, distinguishing their damaging actions from their protective functions [12].

For bone, this cuts both ways. Any substance said to promote vessel growth raises an open safety question about where else that growth might occur. No study among the sources cited here has examined that question in people. Our evidence guide discusses these safety unknowns more broadly.

Human evidence: none on bone in the cited sources

None of the human reports cited on this page concern bone. The human literature is small and covers other questions:

• A 2021 report described intra-articular injection in people with several types of knee pain [5]. Its subject was knee pain, not bone.

• A 2025 pilot study examined the safety of intravenous infusion in humans [6]. Its subject was safety, not bone or any tissue repair.

• A 2026 systematic review assessed the human evidence for BPC-157 in orthopaedic and regenerative medicine, covering both efficacy and safety [7]. That review is the place to check the full scope of published human work.

Any statement that BPC-157 has been shown to affect fractures, bone defects or bone density in humans is not supported by any source cited here.

Regulatory context

FDA's page of bulk drug substances for compounding that may present significant safety risks includes an entry for BPC-157 [2]. FDA's Pharmacy Compounding Advisory Committee met on 23–24 July 2026, and the meeting record is published on FDA's site [3]. WADA's Prohibited List is the reference for its status in sport [4]. Suspected adverse events involving any unapproved product can be reported to FDA through MedWatch [8].

Further reading: evaluating animal research

Animal bone experiments are best read with a grounding in experimental design. Useful skills include judging whether a control group is adequate, whether outcome scoring was blinded, and how small sample sizes distort results. A good research-methods or evidence-appraisal book makes those skills portable to any field.

When comparing titles, look for a few practical things. Does it have a dedicated chapter on animal studies and translation to humans? Does it explain statistics plainly, with worked examples? Is the edition recent? Is it available in a convenient format, whether print, e-book or audio? Compare list prices across formats too, since methods books vary widely in cost. Books written for general readers, often by epidemiologists or science journalists, tend to be more readable than graduate textbooks while still covering bias, confounding and replication well.

We pick reading-list titles on clarity and accuracy, not on commission rates. Any link placed in this slot follows the disclosure rules described on our About page.

A useful test before buying is to read a sample chapter on study design. If it makes randomisation and blinding easy to follow, the rest of the book probably will too.

Frequently asked questions

Are there any human studies of BPC-157 and bone?

None of the human reports cited here concern bone; they cover knee pain and intravenous safety [5][6]. A 2026 systematic review of the human evidence in orthopaedic and regenerative medicine is the reference for the full scope of that small body of work [7].

What kinds of animal models are used in bone research?

Rabbit segmental-defect models and rodent fracture models are typical. They are usually assessed with X-ray imaging, densitometry, microscopy of tissue slices and sometimes mechanical testing. We do not report specific BPC-157 bone results because the primary papers are not among our verified sources.

Who did most of the BPC-157 bone research?

Most BPC-157 research came from the same Zagreb group that originated the compound. Clear independent replication of bone findings is not documented in the sources we cite. That is a significant limitation for any single-group literature.

Does the animal bone research change BPC-157's legal status?

No. BPC-157 is not FDA-approved, FDA's compounding safety-risk page includes an entry for it [2], and it is prohibited in sport [4]. Animal findings do not alter that status.

Related on this site

• BPC-157: the evidence file

• BPC-157 animal studies: what rodent models can and cannot show

• BPC-157 tendon research: what the rodent studies examined

• BPC-157: what the evidence actually shows (and doesn't)

• Is BPC-157 legal? FDA, compounding and anti-doping status

• How to evaluate a BPC-157 study: a reader's checklist and reading list

Last updated: 22 October 2026.

Not medical advice. This page reports published research and regulatory records for information only.

Research-only notice: Content on this site is provided for research and educational purposes only and is not intended for human use. It is not medical advice.

Translation notice: Some content on this site may have been machine-translated using Google Translate and may contain errors.